IP Library Granted Patent US 11,884,918
Granted Patent B2
US 11,884,918 · App. 17/384,328 · Granted Jan 30, 2024

Systems and methods for modulating CRISPR activity

Inventors: Reed Kelso (San Francisco, CA); Jared Carlson-Stevermer (Burlingame, CA); Sahil Joshi (Somerville, MA); Travis Maures (La Jolla, CA); Anastasia Kadina (Sunnyvale, CA); John Andrew Walker, II (San Leandro, CA)
Assignee: Synthego Corporation
C12N15/111C12N9/22C12N15/102C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,884,918
App. No.
17/384,328
Granted
Jan 30, 2024
Kind
B2
Abstract

Provided herein are polynucleotides comprising sequence configured to bind to a CRISPR effector protein. Modulation of one or more modifications of the polynucleotides can be used to tune the activity of CRISPR effector proteins complexed with the polynucleotides.

Claims (22)

1. A CRISPR OFF polynucleotide comprising:

(a) a guide sequence configured to anneal to a target sequence in a target nucleic acid molecule;

(b) a sequence configured to bind to a CRISPR enzyme; and

(c) a cleavable linker positioned at position 57 and/or 74 in the sequence configured to bind to the CRISPR enzyme wherein position 1 is at a 5′ end of the guide sequence and positions are counted from 5′ to 3′, and wherein the CRISPR OFF polynucleotide is inactivated when the cleavable linker is cleaved.

2. The CRISPR OFF polynucleotide of claim 1 , wherein the cleavable linker is a photocleavable linker.

3. The CRISPR OFF polynucleotide of claim 1 (c), wherein the photocleavable linker is cleaved by visible light.

4. The CRISPR OFF polynucleotide of claim 1 (c), wherein the photocleavable linker is cleaved by ultraviolet (UV) light.

5. The CRISPR OFF polynucleotide of claim 1 (c), wherein the photocleavable linker comprises a compound of Formula:

wherein

* indicates a point of attachment to H, or a first nucleotide; and

** indicates a point of attachment to OH, or a second nucleotide.

6. The CRISPR OFF polynucleotide of claim 1 (c), wherein the photocleavable linker comprises a compound of Formula:

wherein:

R 1 , R 2 , R 3 , R 4 , and R 5 are each independently selected from H, alkyl, substituted alkyl, alkoxy, alkenyl, alkynyl, haloalkyl, haloalkoxy, alkoxyalkyl, amino, aminoalkyl, halo, cyano, hydroxy, hydroxyalkyl, heteroalkyl, C-carboxy, O-carboxy, C-amido, N-amido, nitro, sulfonyl, sulfo, sulfino, sulfonate, S-sulfonamido, N-sulfonamido, optionally substituted carbocyclyl, optionally substituted aryl, optionally substituted heteroaryl and optionally substituted heterocyclyl;

alternatively, two or more of R 1 , R 2 , R 3 , and R 4 , together with the atoms to which they are attached form a ring or ring system selected from optionally substituted 5- to 10-membered heteroaryl, optionally substituted 5- to 10-membered heterocyclyl, and optionally substituted C 5-10 carbocycle; and

m is an integer selected from 2 to 10; and

X is selected from O, S, or dicyanomethylene; and

* indicates a point of attachment to H, or a first nucleotide; and

** indicates a point of attachment to OH, or a second nucleotide.

7. The CRISPR OFF polynucleotide of claim 1 (c), wherein the CRISPR OFF polynucleotide further comprises a photocaging group.

8. The CRISPR OFF polynucleotide of claim 7 , wherein the photocaging group is an ortho-nitrobenzyl group.

9. The CRISPR OFF polynucleotide of claim 1 , wherein the cleavable linker is positioned at position 57 and 74, wherein position 1 is at a 5′ end of the guide sequence, and positions are counted from 5′ to 3′.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2022
From: KELSO, REED; CARLSON-STEVERMER, JARED; JOSHI, SAHIL; MAURES, TRAVIS; KADINA, ANASTASIA; WALKER, JOHN ANDREW, II
To: SYNTHEGO CORPORATION
Reel/Frame 058773/0971 →
PATENT SECURITY AGREEMENT Recorded Jan 24, 2022
From: SYNTHEGO CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 058829/0401 →
Continuity (5)
Continuation PCTUS2020015127 · Jan 25, 2020
Provisional Application 62939553 · Nov 22, 2019
Provisional Application 62876177 · Jul 19, 2019
Provisional Application 62797122 · Jan 25, 2019
Related Publication 20220073912A1 · Mar 10, 2022